ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 94 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,840,000 | -29.1% | 346,500 | -28.0% | 0.31% | -75.4% |
| Q4 2020 | $2,594,000 | +77.2% | 481,284 | +162.3% | 1.24% | +763.9% |
| Q3 2020 | $1,464,000 | -41.7% | 183,480 | -0.8% | 0.14% | +4.3% |
| Q3 2018 | $2,509,000 | +164.1% | 185,000 | +131.2% | 0.14% | +130.0% |
| Q2 2018 | $950,000 | -79.7% | 80,000 | -80.8% | 0.06% | -88.1% |
| Q1 2018 | $4,677,000 | +7.9% | 416,457 | -35.8% | 0.50% | -36.7% |
| Q4 2017 | $4,333,000 | +33.7% | 648,645 | +63.9% | 0.80% | +435.6% |
| Q3 2017 | $3,242,000 | +437.6% | 395,824 | +691.6% | 0.15% | +52.0% |
| Q4 2015 | $603,000 | – | 50,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
| Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
| Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
| NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
| Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
| Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
| DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
| PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
| Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |